HP-NAP activates neutrophils and monocytes, promoting IL-12 and IL-23 production, which polarizes a CD4 + T cell response into an anti-tumor Th1 response characterized by increased IFN-γ and TNF-α [217]. This evidence concerns the gene CD4 and neoplasm.